MV Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

MV Capital Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6	Closed	-$242	–	1282
2026 Q1	$242	Sell	6 -3	-33%	-$65	﹤0.01%	1056
2025 Q4	$227	Buy	9 +1	+13%	+$23	﹤0.01%	1013
2025 Q3	$182	Hold	8	–	–	﹤0.01%	948
2025 Q2	$139	Buy	8 +2	+33%	+$37	﹤0.01%	974
2025 Q1	$132	Sell	6 -23	-79%	-$635	﹤0.01%	967
2024 Q4	$926	Buy	29 +25	+625%	+$752	﹤0.01%	756
2024 Q3	$116	Buy	4 +2	+100%	+$74	﹤0.01%	949
2024 Q2	$77	Buy	+2	New	+$91	﹤0.01%	920

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MV Capital Management's APLS Position: Q2 2026 in Review

MV Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 6 shares — an estimated $242 sold.

MV Capital Management first reported a position in APLS in Q2 2024 and held it in 8 quarters. The position peaked at $926 in Q4 2024. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

MV Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
MV Capital Management sold 6 Apellis Pharmaceuticals shares in Q2 2026, an estimated $242.
MV Capital Management first reported a position in Apellis Pharmaceuticals in Q2 2024 and held it in 8 quarters.
MV Capital Management's Apellis Pharmaceuticals position peaked at $926 in Q4 2024.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.